John Jackson, MD
Procedural Dermatology · Fort Myers, FLNPI 1558653725
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $281 of the $381 with a category attached, or 73.7%. 6 manufacturers reported payments, led by Johnson & Johnson at 36.3% of the total. Reporting peaked in 2023 at $263 and has fallen 81.0% since, to $50 in 2025. That places this record below the midpoint for procedural dermatology clinicians in FL, where the typical reported total is $1,299.
Across 12 payments — averaging $31.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$138
- Sun Pharmaceutical Industries Inc.$116
- AbbVie$74
- Lilly USA, LLC$23
- Pfizer$15
- Galderma Laboratories, L.p.$15
What the payments were for
- Food & beverage$28174%
- Education$10026%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 3 | $138 |
| Sun Pharmaceutical Industries Inc. | 2 | $116 |
| AbbVie | 4 | $74 |
| Lilly USA, LLC | 1 | $23 |
| Pfizer | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $15 |
How this compares
$381 in reported general payments places this provider in the 25th percentile of 60 procedural dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 13 | $64,577 |
| Dupixent SyringeDupilumab | 15 | $56,433 |
| Clobetasol Propionate | 216 | $9,195 |
| Fluorouracil | 113 | $8,304 |
| Tacrolimus | 33 | $3,372 |
| Fluocinolone Acetonide | 40 | $2,212 |
| Ketoconazole | 195 | $2,183 |
| Doxycycline Hyclate | 75 | $2,073 |
| Fluocinonide | 38 | $1,868 |
| Metronidazole | 30 | $1,603 |
| Calcipotriene | 13 | $1,282 |
| Triamcinolone Acetonide | 136 | $978 |
| Minoxidil | 75 | $792 |
| ValacyclovirValacyclovir Hcl | 34 | $756 |
| Imiquimod | 16 | $499 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Fort Myers
- Laertes ManuelidisFort Myers$252K
- Anthony FranswayFort Myers$2K
- Stanley SchwartzFort Myers$1K
- Shari SkinnerFort Myers$1K
- Keith BenbenisyFort Myers$738
- Kip CullimoreFort Myers$57
- Luis SoroFort Lauderdale$307K
- Michael ScannonTampa$218K
- Christopher OconnellCoral Gables$76K
- Dimitry PalceskiWinter Park$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.